Triple agonism (Retatrutide) adds the glucagon receptor, which in preclinical models is linked to increased hepatic lipid oxidation and energy expenditure beyond what incretin signaling alone produces
We're excited to announce that Doctor Care Anywhere has acquired Medicspot, a leading UK weight loss management business
By significantly slowing digestion, GLP-1 drugs may increase the risk of severe digestive complications in some patients, according to the allegations made in these cases
Can GLP-1 medications help with insulin resistance
Gostou deste contedo e quer se aprofundar em Nutrologia e sade baseada em evidncias
152: 156165, doi: Gatti R, De Palo EF, Antonelli G, Spinella P